| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.841 | 0.004 | 0.895 | Antioxidant | 0.895 0.004 CID_154699819 | CID_154699819 | |
| 0.766 | 0.004 | 0.766 | Lipoxygenase inhibitor | 0.294 0.074 CID_154699819 | ||
| 0.765 | 0.005 | 0.765 | Amyloid beta aggregation inhibitor | 0.594 0.008 CID_154699819 | ||
| 0.745 | 0.004 | 0.81 | Free radical scavenger | 0.81 0.004 CID_154699819 | CID_154699819 | |
| 0.738 | 0.019 | 0.738 | Caspase 9 stimulant | 0.729 0.02 CID_154699819 | ||
| 0.712 | 0.019 | 0.926 | Transcription factor NF kappa B inhibitor | 0.926 0.004 CID_154699819 | CID_154699819 | |
| 0.693 | 0.032 | 0.756 | Apoptosis agonist | 0.756 0.022 CID_154699819 | CID_154699819 | |
| 0.635 | 0.011 | 0.635 | 5 Hydroxytryptamine release stimulant | 0.507 0.026 CID_154699819 | ||
| 0.609 | 0.004 | 0.609 | 5-Lipoxygenase inhibitor | 0.259 0.014 CID_154699819 | ||
| 0.605 | 0.002 | 0.605 | HIV-1 integrase (Strand Transfer) inhibitor | 0.426 0.004 CID_154699819 | ||
| 0.588 | 0.02 | 0.588 | Aldehyde oxidase inhibitor | |||
| 0.601 | 0.053 | 0.814 | Antiinflammatory | 0.814 0.013 CID_154699819 | CID_154699819 | |
| 0.544 | 0.012 | 0.663 | Antiamyloidogenic | 0.663 0.005 CID_154699819 | CID_154699819 | |
| 0.534 | 0.01 | 0.534 | Superoxide dismutase inhibitor | |||
| 0.51 | 0.019 | 0.51 | Caspase 3 stimulant | 0.475 0.024 CID_154699819 | ||
| 0.449 | 0.008 | 0.654 | DNA methylase inhibitor | 0.654 0.003 CID_154699819 | CID_154699819 | |
| 0.442 | 0.003 | 0.442 | HIV-1 integrase inhibitor | 0.234 0.004 CID_154699819 | ||
| 0.45 | 0.012 | 0.45 | P-glycoprotein inhibitor | 0.349 0.021 CID_154699819 | ||
| 0.441 | 0.006 | 0.639 | DNA methyltransferase I inhibitor | 0.639 0.003 CID_154699819 | CID_154699819 | |
| 0.435 | 0.004 | 0.435 | Vanilloid agonist | 0.219 0.006 CID_154699819 | ||
| 0.431 | 0.005 | 0.431 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.422 | 0.004 | 0.422 | HIV-1 integrase (3'-Processing) inhibitor | 0.25 0.007 CID_154699819 | ||
| 0.418 | 0.011 | 0.775 | Monophenol monooxygenase inhibitor | 0.775 0.003 CID_154699819 | CID_154699819 | |
| 0.436 | 0.031 | 0.436 | 12-Lipoxygenase inhibitor | |||
| 0.406 | 0.002 | 0.406 | HIV-1 integrase (Overall Integration) inhibitor | 0.101 0.053 CID_154699819 | ||
| 0.38 | 0.003 | 0.38 | Vanilloid 1 agonist | 0.327 0.004 CID_154699819 | ||
| 0.4 | 0.026 | 0.566 | Nitric oxide antagonist | 0.566 0.012 CID_154699819 | CID_154699819 | |
| 0.389 | 0.027 | 0.42 | Hypolipemic | 0.42 0.022 CID_154699819 | CID_154699819 | |
| 0.409 | 0.052 | 0.412 | Vasodilator, peripheral | 0.412 0.052 CID_154699819 | CID_154699819 | |
| 0.412 | 0.058 | 0.535 | Immunosuppressant | 0.535 0.024 CID_154699819 | CID_154699819 | |
| 0.371 | 0.02 | 0.371 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.425 | 0.078 | 0.765 | Cyclophilin D inhibitor | 0.765 0.009 CID_154699819 | CID_154699819 | |
| 0.406 | 0.072 | 0.406 | 15-Lipoxygenase inhibitor | |||
| 0.338 | 0.017 | 0.531 | Melanin inhibitor | 0.531 0.006 CID_154699819 | CID_154699819 | |
| 0.334 | 0.015 | 0.438 | Lipid peroxidase inhibitor | 0.438 0.008 CID_154699819 | CID_154699819 | |
| 0.375 | 0.055 | 0.601 | Cholesterol antagonist | 0.601 0.019 CID_154699819 | CID_154699819 | |
| 0.32 | 0.013 | 0.372 | Neurotrophic factor enhancer | 0.372 0.007 CID_154699819 | CID_154699819 | |
| 0.35 | 0.056 | 0.538 | Apoptosis antagonist | 0.538 0.016 CID_154699819 | CID_154699819 | |
| 0.301 | 0.01 | 0.301 | Succinate dehydrogenase inhibitor | |||
| 0.291 | 0.006 | 0.382 | Carbonic anhydrase XIII inhibitor | 0.382 0.004 CID_154699819 | CID_154699819 | |
| 0.293 | 0.01 | 0.293 | Cystathionine beta-synthase inhibitor | 0.247 0.016 CID_154699819 | ||
| 0.378 | 0.097 | 0.378 | Calcium channel L-type activator | |||
| 0.277 | 0.003 | 0.277 | Transcription factor AP-1 inhibitor | 0.227 0.004 CID_154699819 | ||
| 0.277 | 0.004 | 0.277 | Thioredoxin inhibitor | 0.256 0.004 CID_154699819 | ||
| 0.282 | 0.009 | 0.282 | Carbonic anhydrase XV inhibitor | |||
| 0.287 | 0.019 | 0.465 | Protein kinase stimulant | 0.465 0.005 CID_154699819 | CID_154699819 | |
| 0.275 | 0.007 | 0.275 | Carbonic anhydrase VI inhibitor | 0.146 0.022 CID_154699819 | ||
| 0.366 | 0.102 | 0.418 | 5 Hydroxytryptamine release inhibitor | 0.418 0.067 CID_154699819 | CID_154699819 | |
| 0.259 | 0.005 | 0.259 | Keratolytic | 0.069 0.068 CID_154699819 | ||
| 0.267 | 0.014 | 0.267 | DNA polymerase I inhibitor | 0.247 0.017 CID_154699819 | ||
| 0.249 | 0.002 | 0.249 | Glucose-6-phosphate translocase inhibitor | 0.218 0.002 CID_154699819 | ||
| 0.297 | 0.054 | 0.583 | Tumour necrosis factor alpha release inhibitor | 0.583 0.008 CID_154699819 | CID_154699819 | |
| 0.342 | 0.103 | 0.503 | Histamine release inhibitor | 0.503 0.028 CID_154699819 | CID_154699819 | |
| 0.272 | 0.038 | 0.504 | Hepatoprotectant | 0.504 0.007 CID_154699819 | CID_154699819 | |
| 0.307 | 0.073 | 0.307 | Sodium/bile acid cotransporter inhibitor | 0.212 0.172 CID_154699819 | ||
| 0.245 | 0.028 | 0.245 | Histone acetyltransferase inhibitor | |||
| 0.26 | 0.045 | 0.26 | Peroxidase inhibitor | |||
| 0.222 | 0.008 | 0.222 | TRPA1 agonist | 0.156 0.027 CID_154699819 | ||
| 0.3 | 0.087 | 0.466 | Vasodilator, coronary | 0.466 0.021 CID_154699819 | CID_154699819 | |
| 0.281 | 0.071 | 0.281 | Insulysin inhibitor | |||
| 0.3 | 0.091 | 0.3 | Calcium channel activator | |||
| 0.246 | 0.044 | 0.246 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.184 0.088 CID_154699819 | ||
| 0.234 | 0.033 | 0.566 | Amylase inhibitor | 0.566 0.004 CID_154699819 | CID_154699819 | |
| 0.206 | 0.006 | 0.206 | DOPA decarboxylase inhibitor | |||
| 0.21 | 0.024 | 0.21 | Cholesterol synthesis inhibitor | 0.136 0.052 CID_154699819 | ||
| 0.204 | 0.022 | 0.204 | Toll-Like receptor 2 antagonist | |||
| 0.23 | 0.052 | 0.516 | Non-steroidal antiinflammatory agent | 0.516 0.006 CID_154699819 | CID_154699819 | |
| 0.188 | 0.017 | 0.261 | Topoisomerase II alpha inhibitor | 0.261 0.009 CID_154699819 | CID_154699819 | |
| 0.18 | 0.01 | 0.2 | Toll-Like receptor 4 antagonist | 0.2 0.006 CID_154699819 | CID_154699819 | |
| 0.208 | 0.038 | 0.208 | Phospholipase A2 inhibitor | 0.151 0.073 CID_154699819 | ||
| 0.198 | 0.034 | 0.198 | Arachidonic acid antagonist | |||
| 0.188 | 0.027 | 0.188 | Chelator | 0.111 0.063 CID_154699819 | ||
| 0.172 | 0.013 | 0.172 | Electron transport complex I inhibitor | 0.117 0.051 CID_154699819 | ||
| 0.196 | 0.038 | 0.196 | Tubulin antagonist | |||
| 0.221 | 0.064 | 0.227 | Anesthetic general | 0.227 0.061 CID_154699819 | CID_154699819 | |
| 0.193 | 0.037 | 0.193 | Cyclooxygenase 1 inhibitor | 0.138 0.064 CID_154699819 | ||
| 0.188 | 0.033 | 0.188 | Neurotrophic factor | 0.15 0.059 CID_154699819 | ||
| 0.217 | 0.064 | 0.223 | Nitric-oxide synthase stimulant | 0.223 0.056 CID_154699819 | CID_154699819 | |
| 0.177 | 0.025 | 0.304 | Xanthine oxidase inhibitor | 0.304 0.007 CID_154699819 | CID_154699819 | |
| 0.179 | 0.027 | 0.179 | Adenylate cyclase stimulant | 0.125 0.114 CID_154699819 | ||
| 0.202 | 0.056 | 0.202 | Amyloid beta precursor protein antagonist | |||
| 0.179 | 0.042 | 0.19 | Alkaline phosphatase inhibitor | 0.19 0.037 CID_154699819 | CID_154699819 | |
| 0.148 | 0.013 | 0.148 | Glutamate decarboxylase inhibitor | |||
| 0.148 | 0.02 | 0.148 | Histidine decarboxylase inhibitor | |||
| 0.153 | 0.031 | 0.173 | Mucolytic | 0.173 0.021 CID_154699819 | CID_154699819 | |
| 0.138 | 0.017 | 0.138 | Carbonic anhydrase V inhibitor | |||
| 0.147 | 0.029 | 0.147 | Carbonic anhydrase III inhibitor | 0.093 0.071 CID_154699819 | ||
| 0.171 | 0.056 | 0.333 | Interferon gamma antagonist | 0.333 0.016 CID_154699819 | CID_154699819 | |
| 0.129 | 0.019 | 0.129 | HIV-1 reverse transcriptase inhibitor | |||
| 0.126 | 0.02 | 0.203 | Phosphodiesterase 6D inhibitor | 0.203 0.004 CID_154699819 | CID_154699819 | |
| 0.143 | 0.038 | 0.471 | Expectorant | 0.471 0.004 CID_154699819 | CID_154699819 | |
| 0.173 | 0.069 | 0.173 | Phospholipase C inhibitor | |||
| 0.152 | 0.051 | 0.152 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.17 | 0.07 | 0.288 | ATPase inhibitor | 0.288 0.007 CID_154699819 | CID_154699819 | |
| 0.12 | 0.02 | 0.138 | ATPase (Vacuolar H+) inhibitor | 0.138 0.011 CID_154699819 | CID_154699819 | |
| 0.122 | 0.024 | 0.122 | Ornithine decarboxylase inhibitor | 0.084 0.062 CID_154699819 | ||
| 0.111 | 0.015 | 0.111 | Estrogen-related receptor beta agonist | |||
| 0.14 | 0.044 | 0.14 | MAO A inhibitor | |||
| 0.157 | 0.064 | 0.157 | Cyclooxygenase inhibitor | 0.124 0.094 CID_154699819 | ||
| 0.146 | 0.053 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.137 0.085 CID_154699819 | ||
| 0.206 | 0.115 | 0.301 | Interleukin agonist | 0.301 0.048 CID_154699819 | CID_154699819 | |
| 0.145 | 0.054 | 0.151 | Interleukin 4 antagonist | 0.151 0.048 CID_154699819 | CID_154699819 | |
| 0.104 | 0.014 | 0.104 | GABA B receptor agonist | |||
| 0.142 | 0.055 | 0.308 | Cyclooxygenase 3 inhibitor | 0.308 0.005 CID_154699819 | CID_154699819 | |
| 0.18 | 0.093 | 0.18 | Pyruvate kinase inhibitor | |||
| 0.122 | 0.037 | 0.151 | Uric acid excretion stimulant | 0.151 0.023 CID_154699819 | CID_154699819 | |
| 0.209 | 0.123 | 0.209 | Transcription factor STAT3 inhibitor | |||
| 0.09 | 0.005 | 0.09 | Factor III inhibitor | 0.086 0.006 CID_154699819 | ||
| 0.1 | 0.016 | 0.1 | Carbonic anhydrase VB inhibitor | |||
| 0.091 | 0.007 | 0.091 | Vanilloid 2 antagonist | |||
| 0.129 | 0.047 | 0.17 | Photosensitizer | 0.17 0.021 CID_154699819 | CID_154699819 | |
| 0.13 | 0.047 | 0.13 | Falcipain 3 inhibitor | |||
| 0.227 | 0.146 | 0.637 | Antithrombotic | 0.637 0.013 CID_154699819 | CID_154699819 | |
| 0.12 | 0.041 | 0.12 | Sphingomyelinase inhibitor | 0.096 0.064 CID_154699819 | ||
| 0.101 | 0.022 | 0.101 | Beta tubulin antagonist | |||
| 0.095 | 0.017 | 0.12 | Neuraminidase inhibitor | 0.12 0.01 CID_154699819 | CID_154699819 | |
| 0.177 | 0.099 | 0.177 | Insulin sensitizer | |||
| 0.105 | 0.028 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.142 | 0.067 | 0.146 | Heat shock protein 70 antagonist | 0.146 0.055 CID_154699819 | CID_154699819 | |
| 0.088 | 0.013 | 0.126 | Leukotriene B4 antagonist | 0.126 0.007 CID_154699819 | CID_154699819 | |
| 0.106 | 0.031 | 0.106 | Macrophage migration inhibitory factor inhibitor | |||
| 0.097 | 0.023 | 0.097 | Leukotriene antagonist | 0.075 0.036 CID_154699819 | ||
| 0.133 | 0.059 | 0.133 | Aldehyde dehydrogenase inhibitor | 0.116 0.075 CID_154699819 | ||
| 0.107 | 0.034 | 0.107 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.129 | 0.057 | 0.129 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.098 | 0.026 | 0.098 | Transforming growth factor beta 3 antagonist | |||
| 0.098 | 0.027 | 0.098 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.097 | 0.029 | 0.097 | Lipase inhibitor | 0.071 0.054 CID_154699819 | ||
| 0.134 | 0.066 | 0.134 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.086 | 0.018 | 0.086 | Alpha tubulin antagonist | |||
| 0.118 | 0.051 | 0.118 | GABA C receptor agonist | |||
| 0.11 | 0.047 | 0.11 | Breast cancer-resistant protein inhibitor | |||
| 0.124 | 0.064 | 0.263 | Topoisomerase II inhibitor | 0.263 0.023 CID_154699819 | CID_154699819 | |
| 0.108 | 0.048 | 0.108 | Prolactin inhibitor | |||
| 0.074 | 0.014 | 0.074 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.242 | 0.185 | 0.642 | Antibacterial | 0.642 0.014 CID_154699819 | CID_154699819 | |
| 0.107 | 0.051 | 0.107 | Estrogen receptor beta antagonist | |||
| 0.186 | 0.132 | 0.31 | Spasmolytic | 0.31 0.066 CID_154699819 | CID_154699819 | |
| 0.128 | 0.074 | 0.128 | Toll-Like receptor antagonist | |||
| 0.13 | 0.076 | 0.13 | Interleukin 1 antagonist | |||
| 0.124 | 0.073 | 0.124 | MAO inhibitor | |||
| 0.109 | 0.058 | 0.333 | Beta glucuronidase inhibitor | 0.333 0.005 CID_154699819 | CID_154699819 | |
| 0.067 | 0.018 | 0.067 | Leukotriene C antagonist | |||
| 0.199 | 0.15 | 0.199 | Gastrin inhibitor | |||
| 0.115 | 0.065 | 0.115 | Estrogen antagonist | |||
| 0.056 | 0.007 | 0.056 | Catechol O-methyltransferase inhibitor | |||
| 0.135 | 0.088 | 0.135 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.051 | 0.004 | 0.051 | Calcium-independent phospholipase A2 inhibitor | 0.038 0.014 CID_154699819 | ||
| 0.162 | 0.115 | 0.658 | Angiogenesis stimulant | 0.658 0.005 CID_154699819 | CID_154699819 | |
| 0.123 | 0.077 | 0.123 | Cyclooxygenase 2 inhibitor | |||
| 0.174 | 0.128 | 0.351 | Vasodilator | 0.351 0.033 CID_154699819 | CID_154699819 | |
| 0.101 | 0.055 | 0.101 | DNA directed RNA polymerase inhibitor | |||
| 0.103 | 0.06 | 0.103 | Bronchodilator | 0.088 0.077 CID_154699819 | ||
| 0.079 | 0.037 | 0.079 | Secretase beta inhibitor | |||
| 0.113 | 0.071 | 0.113 | Proteasome inhibitor | |||
| 0.055 | 0.014 | 0.055 | Dopamine D5 agonist | |||
| 0.097 | 0.057 | 0.098 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.098 0.056 CID_154699819 | CID_154699819 | |
| 0.147 | 0.108 | 0.147 | Neurotensin receptor agonist | |||
| 0.1 | 0.063 | 0.1 | Anabolic | |||
| 0.133 | 0.097 | 0.142 | Protein-tyrosine phosphatase inhibitor | 0.142 0.087 CID_154699819 | CID_154699819 | |
| 0.096 | 0.06 | 0.096 | Bile acid receptor antagonist | |||
| 0.176 | 0.14 | 0.176 | RNA-directed DNA polymerase inhibitor | |||
| 0.052 | 0.017 | 0.052 | Estrogen receptor alpha agonist | |||
| 0.047 | 0.012 | 0.047 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.081 | 0.046 | 0.081 | GABA aminotransferase inhibitor | |||
| 0.164 | 0.13 | 0.355 | Cyclic AMP phosphodiesterase inhibitor | 0.355 0.025 CID_154699819 | CID_154699819 | |
| 0.078 | 0.045 | 0.09 | Phosphodiesterase VI inhibitor | 0.09 0.028 CID_154699819 | CID_154699819 | |
| 0.08 | 0.047 | 0.08 | Porphobilinogen synthase inhibitor | |||
| 0.193 | 0.161 | 0.212 | Hypoxia-inducible factor 1 alpha inhibitor | 0.212 0.139 CID_154699819 | CID_154699819 | |
| 0.118 | 0.086 | 0.118 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.055 | 0.023 | 0.055 | Carbonic anhydrase VII inhibitor | |||
| 0.105 | 0.074 | 0.133 | Protein-tyrosine phosphatase 1B inhibitor | 0.133 0.054 CID_154699819 | CID_154699819 | |
| 0.074 | 0.044 | 0.131 | Phosphofructokinase-1 inhibitor | 0.131 0.022 CID_154699819 | CID_154699819 | |
| 0.047 | 0.019 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.172 | 0.145 | 0.578 | Hypoglycemic | 0.578 0.009 CID_154699819 | CID_154699819 | |
| 0.061 | 0.034 | 0.061 | Beta 1 adrenoreceptor antagonist | |||
| 0.066 | 0.04 | 0.066 | Beta 3 adrenoreceptor antagonist | |||
| 0.059 | 0.033 | 0.059 | Sphingosine kinase 2 inhibitor | |||
| 0.068 | 0.042 | 0.068 | Beta adrenoreceptor antagonist | |||
| 0.033 | 0.008 | 0.033 | Prostaglandin F2 alpha agonist | |||
| 0.129 | 0.104 | 0.129 | Sigma receptor agonist | |||
| 0.105 | 0.081 | 0.123 | Microtubule formation inhibitor | 0.123 0.057 CID_154699819 | CID_154699819 | |
| 0.065 | 0.041 | 0.065 | Calcium channel P-type blocker | |||
| 0.053 | 0.03 | 0.053 | Plasminogen activator inhibitor antagonist | |||
| 0.042 | 0.019 | 0.042 | Leukotriene C4 antagonist | |||
| 0.069 | 0.047 | 0.069 | Carbonic anhydrase VA inhibitor | |||
| 0.082 | 0.063 | 0.082 | Myeloperoxidase inhibitor | |||
| 0.044 | 0.026 | 0.044 | Heme oxygenase inhibitor | |||
| 0.053 | 0.035 | 0.053 | Aconitate hydratase inhibitor | |||
| 0.049 | 0.031 | 0.058 | Glucose-6-phosphate isomerase inhibitor | 0.058 0.02 CID_154699819 | CID_154699819 | |
| 0.07 | 0.053 | 0.07 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.223 | 0.207 | 0.223 | Transcription factor inhibitor | |||
| 0.057 | 0.041 | 0.057 | Xanthine dehydrogenase inhibitor | |||
| 0.058 | 0.043 | 0.058 | Ryanodine receptor antagonist | |||
| 0.074 | 0.059 | 0.074 | Estrogen receptor alpha antagonist | |||
| 0.1 | 0.087 | 0.1 | Acetylcholine release stimulant | |||
| 0.062 | 0.049 | 0.062 | Transcription factor RelA inhibitor | |||
| 0.167 | 0.154 | 0.366 | Peptidyltransferase inhibitor | 0.366 0.01 CID_154699819 | CID_154699819 | |
| 0.025 | 0.013 | 0.025 | CYP24 inhibitor | |||
| 0.047 | 0.036 | 0.047 | Dopamine beta hydroxylase inhibitor | |||
| 0.056 | 0.046 | 0.056 | Sphingosine kinase inhibitor | |||
| 0.087 | 0.077 | 0.153 | UDP-glucose 4-epimerase inhibitor | 0.153 0.028 CID_154699819 | CID_154699819 | |
| 0.055 | 0.045 | 0.055 | Pregnane X receptor antagonist | |||
| 0.032 | 0.022 | 0.032 | ATP citrate lysase inhibitor | |||
| 0.12 | 0.11 | 0.327 | Thrombolytic | 0.327 0.02 CID_154699819 | CID_154699819 | |
| 0.067 | 0.058 | 0.067 | Aminopeptidase I inhibitor | |||
| 0.062 | 0.053 | 0.062 | Leukotriene synthesis inhibitor | |||
| 0.031 | 0.022 | 0.031 | Prostaglandin agonist | |||
| 0.047 | 0.038 | 0.061 | Estrogen agonist | 0.061 0.03 CID_154699819 | CID_154699819 | |
| 0.063 | 0.055 | 0.063 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.048 | 0.039 | 0.048 | Beta 2 adrenoreceptor antagonist | |||
| 0.086 | 0.077 | 0.086 | Creatine kinase inhibitor | |||
| 0.109 | 0.101 | 0.109 | Cytokine production inhibitor | |||
| 0.125 | 0.116 | 0.125 | GABA C receptor rho-2 antagonist | |||
| 0.057 | 0.049 | 0.057 | Purinergic P2X1 antagonist | |||
| 0.06 | 0.052 | 0.06 | Beta 2 adrenoreceptor agonist | |||
| 0.054 | 0.046 | 0.054 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.076 | 0.069 | 0.076 | Inducible nitric-oxide synthase inhibitor | |||
| 0.045 | 0.038 | 0.081 | Carbonic anhydrase XIV inhibitor | 0.081 0.016 CID_154699819 | CID_154699819 | |
| 0.121 | 0.114 | 0.286 | NOS3 expression enhancer | 0.286 0.02 CID_154699819 | CID_154699819 | |
| 0.032 | 0.026 | 0.032 | Fumarate hydratase inhibitor | |||
| 0.03 | 0.024 | 0.03 | Cholesterol ester transfer protein antagonist | |||
| 0.033 | 0.027 | 0.033 | Phosphoglycerate kinase inhibitor | |||
| 0.024 | 0.02 | 0.038 | Vanilloid 2 agonist | 0.038 0.004 CID_154699819 | CID_154699819 | |
| 0.029 | 0.024 | 0.029 | Prostaglandin D2 agonist | |||
| 0.036 | 0.031 | 0.036 | Glutamate (mGluR8) agonist | |||
| 0.128 | 0.123 | 0.128 | CF transmembrane conductance regulator agonist | |||
| 0.12 | 0.117 | 0.12 | Thiol protease inhibitor | |||
| 0.148 | 0.145 | 0.148 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.046 | 0.043 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.104 | 0.102 | 0.104 | Bone formation stimulant | |||
| 0.076 | 0.074 | 0.076 | Thioredoxin reductase inhibitor | |||
| 0.085 | 0.084 | 0.085 | Urease inhibitor | |||
| 0.062 | 0.061 | 0.062 | Glutamate (mGluR7) antagonist | |||
| 0.063 | 0.062 | 0.063 | Catalase inhibitor | |||
| 0.011 | 0.01 | 0.011 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.024 | 0.029 | 0.046 | Squalene synthetase inhibitor | 0.046 0.016 CID_154699819 | CID_154699819 | |
| 0.077 | 0.082 | 0.109 | Triose-phosphate isomerase inhibitor | 0.109 0.039 CID_154699819 | CID_154699819 | |
| 0.016 | 0.026 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 CID_154699819 | CID_154699819 | |
| 0.096 | 0.108 | 0.123 | Alpha-N-acetylglucosaminidase inhibitor | 0.123 0.074 CID_154699819 | CID_154699819 | |
| 0.059 | 0.074 | 0.204 | Antineoplastic antibiotic | 0.204 0.02 CID_154699819 | CID_154699819 | |
| 0.039 | 0.055 | 0.106 | Protein 50S ribosomal subunit inhibitor | 0.106 0.012 CID_154699819 | CID_154699819 | |
| 0.038 | 0.054 | 0.082 | Aldose reductase inhibitor | 0.082 0.022 CID_154699819 | CID_154699819 | |
| 0.018 | 0.041 | 0.076 | Sodium/glucose cotransporter 2 inhibitor | 0.076 0.004 CID_154699819 | CID_154699819 | |
| 0.047 | 0.072 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.023 CID_154699819 | CID_154699819 | |
| 0.015 | 0.043 | 0.023 | Dopamine D1 agonist | 0.023 0.015 CID_154699819 | CID_154699819 | |
| 0.07 | 0.1 | 0.104 | NADH dehydrogenase inhibitor | 0.104 0.04 CID_154699819 | CID_154699819 | |
| 0.018 | 0.051 | 0.061 | Sodium/glucose cotransporter inhibitor | 0.061 0.004 CID_154699819 | CID_154699819 | |
| 0.17 | 0.208 | 0.244 | Angiogenesis inhibitor | 0.244 0.128 CID_154699819 | CID_154699819 | |
| 0.132 | 0.172 | 0.424 | Immunostimulant | 0.424 0.043 CID_154699819 | CID_154699819 | |
| 0.04 | 0.079 | 0.097 | Heparanase inhibitor | 0.097 0.004 CID_154699819 | CID_154699819 | |
| 0.048 | 0.089 | 0.094 | Na+ K+ transporting ATPase inhibitor | 0.094 0.037 CID_154699819 | CID_154699819 | |
| 0.181 | 0.225 | 0.379 | Interleukin 2 agonist | 0.379 0.034 CID_154699819 | CID_154699819 | |
| 0.005 | 0.06 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 CID_154699819 | CID_154699819 | |
| 0.061 | 0.12 | 0.153 | Mediator release inhibitor | 0.153 0.027 CID_154699819 | CID_154699819 | |
| 0.073 | 0.141 | 0.111 | Multidrug resistance-associated protein 1 inhibitor | 0.111 0.06 CID_154699819 | CID_154699819 | |
| 0.062 | 0.133 | 0.139 | Transcription factor NF kappa B stimulant | 0.139 0.019 CID_154699819 | CID_154699819 | |
| 0.044 | 0.115 | 0.062 | Lipocortins synthesis agonist | 0.062 0.033 CID_154699819 | CID_154699819 | |
| 0.168 | 0.246 | 0.51 | Alpha-glucosidase inhibitor | 0.51 0.078 CID_154699819 | CID_154699819 | |
| 0.03 | 0.112 | 0.058 | Alpha-mannosidase inhibitor | 0.058 0.029 CID_154699819 | CID_154699819 | |
| 0.022 | 0.104 | 0.052 | Mannosidase inhibitor | 0.052 0.023 CID_154699819 | CID_154699819 | |
| 0.018 | 0.103 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 CID_154699819 | CID_154699819 | |
| 0.012 | 0.128 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 CID_154699819 | CID_154699819 | |
| 0.059 | 0.177 | 0.132 | Alkylator | 0.132 0.057 CID_154699819 | CID_154699819 | |
| 0.024 | 0.143 | 0.319 | Selectin antagonist | 0.319 0.005 CID_154699819 | CID_154699819 | |
| 0.031 | 0.153 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.033 CID_154699819 | CID_154699819 | |
| 0.083 | 0.205 | 0.159 | Hexokinase inhibitor | 0.159 0.069 CID_154699819 | CID_154699819 | |
| 0.058 | 0.184 | 0.166 | AMP-activated protein kinase stimulant | 0.166 0.019 CID_154699819 | CID_154699819 | |
| 0.02 | 0.148 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.045 0.032 CID_154699819 | CID_154699819 | |
| 0.049 | 0.178 | 0.079 | Falcipain inhibitor | 0.079 0.075 CID_154699819 | CID_154699819 | |
| 0.048 | 0.179 | 0.076 | Falcipain 2 inhibitor | 0.076 0.075 CID_154699819 | CID_154699819 | |
| 0.084 | 0.219 | 0.358 | Platelet adhesion inhibitor | 0.358 0.018 CID_154699819 | CID_154699819 | |
| 0.039 | 0.179 | 0.073 | Glycine receptor antagonist | 0.073 0.07 CID_154699819 | CID_154699819 | |
| 0.082 | 0.224 | 0.147 | DNA repair enzyme inhibitor | 0.147 0.034 CID_154699819 | CID_154699819 | |
| 0.06 | 0.21 | 0.106 | Interleukin 12 antagonist | 0.106 0.044 CID_154699819 | CID_154699819 | |
| 0.121 | 0.273 | 0.231 | DNA synthesis inhibitor | 0.231 0.082 CID_154699819 | CID_154699819 | |
| 0.059 | 0.219 | 0.08 | T cell inhibitor | 0.08 0.065 CID_154699819 | CID_154699819 | |
| 0.063 | 0.228 | 0.193 | Cell adhesion inhibitor | 0.193 0.027 CID_154699819 | CID_154699819 | |
| 0.018 | 0.194 | 0.065 | Antibiotic Aminoglycoside-like | 0.065 0.007 CID_154699819 | CID_154699819 | |
| 0.032 | 0.22 | 0.167 | Topoisomerase I inhibitor | 0.167 0.035 CID_154699819 | CID_154699819 | |
| 0.069 | 0.308 | 0.189 | Insulin secretagoues | 0.189 0.042 CID_154699819 | CID_154699819 | |
| 0.065 | 0.311 | 0.244 | Platelet antagonist | 0.244 0.075 CID_154699819 | CID_154699819 | |
| 0.007 | 0.278 | 0.032 | Protein 30S ribosomal subunit inhibitor | 0.032 0.012 CID_154699819 | CID_154699819 | |
| 0.059 | 0.363 | 0.203 | Hemostatic | 0.203 0.031 CID_154699819 | CID_154699819 | |
| 0.055 | 0.369 | 0.142 | Interleukin 6 antagonist | 0.142 0.102 CID_154699819 | CID_154699819 | |
| 0.024 | 0.394 | 0.076 | Cell adhesion molecule inhibitor | 0.076 0.059 CID_154699819 | CID_154699819 | |
| 0.034 | 0.415 | 0.127 | Cell wall synthesis inhibitor | 0.127 0.089 CID_154699819 | CID_154699819 | |
| 0.084 | 0.477 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.069 CID_154699819 | CID_154699819 | |
| 0.018 | 0.557 | 0.162 | Anticoagulant | 0.162 0.071 CID_154699819 | CID_154699819 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |